Lung Neoplasms
334
31
45
161
Key Insights
Highlights
Success Rate
84% trial completion
Published Results
37 trials with published results (11%)
Research Maturity
161 completed trials (48% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
9.0%
30 terminated out of 334 trials
84.3%
-2.2% vs benchmark
7%
24 trials in Phase 3/4
23%
37 of 161 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 161 completed trials
Clinical Trials (334)
Construction and Feasibility Study of a Home-Based Intelligent Symptom Management Program for Lung Cancer Patients Receiving Combined Drug Therapy Based on Symptom Journey Profiling
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study
Sputum Cytometry Analysis in Lung Cancer Screening After Professional Asbestos Exposure
Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC
LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada
Construction and Preliminary Evaluation of Dyadic Acceptance and Commitment Therapy for Couples With Fear of Lung Cancer Recurrence
Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC
Does PEP Compensate the Reduction of Tidal Volume During One Lung Ventilation?
Evaluation of the Utility of Rapid On-site Cytology Performed by an Interventional Pulmonologist During EBUS-TBNA.
Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)
Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder
DeniLA: Comprehensive Demographics and Clinical Profile of NSCLC Patients: Analyzing Guideline-Concordant Care in First-line Treatment Patterns
3D Virtual Resection for Predicting Lung Function in VATS
Confocal Laser Endomicroscopy Nodule Localization by Robotic Bronchoscopy
Advancing Precision Lung Cancer Surveillance and Outcomes in Diverse Populations
Efficacy and Safety Evaluation of Sintilimab in Patients With Advanced or Metastatic Non-squamous NSCLC
Apple Vision Pro-Assisted Vascular Identification in Lung Surgery